Page 152 - SAMRC AnnualReport 2025-26
P. 152

Cardiometabolic Health
                                                               Research Unit





                                                               UNIT DIRECTORS:
                                                               Prof. Glenda Davison
                                                               davisong@cput.ac.za
                                                               Prof. Tandi Matsha
                                                               tandi.matsha-erasmus@smu.ac.za




            Overview of the Research Unit                      Key Milestones and Achievements

            Cardiometabolic disease is rising rapidly in       Goal 1: Investigating immune responses
            Africa  and  South  Africa.  It  is  hypothesised  that   in the development of systemic
            the development of these diseases and their        inflammation and cardiovascular
            complications is due to the complex interaction
            between epigenetic, genetic, behavioural, and      disease (CVD)
            environmental factors,  which  result  in  chronic   Systemic  inflammation  is  a  major  contributor  to
            inflammation  and  the  onset  of  cardiovascular   CVD,  and  endothelial  dysfunction  (ED)  serves  as
            disease, diabetes, renal disease, and other non-   an early indicator. The study aimed to measure
            communicable diseases. Many individuals in         endothelial-associated molecules (V-CAM, I-CAM,
            Africa and South Africa remain undiagnosed and     TNF)  and  to  correlate  the  findings  with  the  CIMT
            untreated.                                         ultrasound test to evaluate whether these cytokines
                                                               could act as early markers of ED and support the use
            To  address  this  challenge,  the  SAMRC/CPUT     of less expensive and standardised tests. The work
            Cardiometabolic Health Research Unit’s mandate     has been completed, and the results are currently
            is to investigate the unique risk factors and      under analysis, showing promising outcomes.
            pathophysiological changes behind  this  group
            of  diseases  and  to  develop  and  propose  early   Goal 2: Investigating the role of single
            biomarkers to identify patients at risk. These studies   nucleotide polymorphisms (SNPs) and
            and investigations have the potential to significantly   miRNAs in the pathogenesis of diabetes
            impact the rising burden of disease and could lead   in this mixed-ancestry community
            to strategies to prevent the onset of cardiovascular   Two studies were conducted. One examined two
            disease.
                                                               SNPs (CRY2 and G6PC) and found that both could
            The    SAMRC/CPUT     Cardiometabolic   Health     predict the risk of diabetes in this population.
            Extramural Unit aims to investigate cardiometabolic   The other measured SNPs in the Fructosamine-3-
            disease using an integrated approach. The unit     Kinase gene and found that these could explain the
            focuses on four key areas: the role of epigenetic   discordance between HbA1c and other measures of
            mechanisms, the oral microbiota, immune function   glycaemia. Both investigations have been published
            and endothelial dysfunction, and the impact of     and provide valuable insights into current and
            environmental and lifestyle factors. A further goal   future biomarkers of diabetic control.
            is to translate these studies into strategies that   A third study examined the expression of three
            will improve the prevention, early detection, and   miRNAs and inflammatory cytokines over two time
            treatment of cardiovascular disease in South Africa.
                                                               points in a cohort of patients with diabetes. The
                                                               study evaluated how potential biomarkers change








            150         SA M R C  A N N U A L R EP O R T 2 0 2 5 / 2 0 2 6
   147   148   149   150   151   152   153   154   155   156   157